{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:24:23Z","timestamp":1767651863125},"reference-count":56,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":6786,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,2]]},"DOI":"10.1111\/j.1600-0404.1997.tb08151.x","type":"journal-article","created":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T11:45:33Z","timestamp":1233229533000},"page":"59-64","source":"Crossref","is-referenced-by-count":41,"special_numbering":"supplement","title":["The implications of Epstein-Barr virus in multiple\u2018 sclerosis - a review"],"prefix":"10.1155","volume":"95","author":[{"given":"M.","family":"Munch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hvas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"M\u00f8ller-Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Haahr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB1","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.6.4.382","article-title":"Epidemiologic evidence for multiple sclerosis as an infection","volume":"6","author":"Kurtzke","year":"1993","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB2","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0140-6736(91)92580-U","article-title":"Just another dubious virus in cells from a patient with multiple sclerosis","volume":"i","author":"Haahr","year":"1991","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1600-0404.1993.tb04080.x","article-title":"Retrovirus-like particles in an Epstein-Barr virus-producing cell line derived from a patient with chronic progressive myelopathy","volume":"87","author":"Sommerlund","year":"1993","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/135245859500100204","article-title":"B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus","volume":"1","author":"Munch","year":"1995","journal-title":"Multiple Sclerosis Clin Lab Res"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000110277","article-title":"Multiple sclerosis as a retroviral disease? Epidemiological considerations in relation to HTLV-I epidemiology","volume":"10","author":"Haahr","year":"1991","journal-title":"Neuroepidemiology"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1212\/WNL.39.6.825","article-title":"A case-control study of multiple sclerosis","volume":"34","author":"Operskalsky","year":"1989","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB7","first-page":"3","volume-title":"McAlpine's multiple sclerosis","author":"Martyn","year":"1991"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000110945","article-title":"Multiple sclerosis is caused by a dual infection with retrovirus and Epstein-Barr virus","volume":"11","author":"Haahr","year":"1992","journal-title":"Neuroepidemiology"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7326\/0003-4819-118-1-199301010-00009","article-title":"Epstein-Barr virus infections: Biology, pathogenesis, and management","volume":"118","author":"Straus","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB10","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1128\/JVI.70.5.3286-3289.1996","article-title":"Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals","volume":"70","author":"Decker","year":"1996","journal-title":"J Virol"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1099\/0022-1317-75-1-85","article-title":"Detection of multiple \u201cEbnotypes\u201d in individual Epstein-Barr virus carriers following lymphocyte transformation by virus derived from peripheral blood and oropharynx","volume":"75","author":"Gratama","year":"1994","journal-title":"J Gen Virol"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB12","doi-asserted-by":"crossref","first-page":"7632","DOI":"10.1073\/pnas.81.23.7632","article-title":"U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2","volume":"81","author":"Dambaugh","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB13","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1099\/0022-1317-72-7-1579","article-title":"The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers","volume":"72","author":"Yao","year":"1991","journal-title":"J Gen Virol"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-1-4613-0705-1_10","volume-title":"Viral infections of humans. Epidemiology and controls","author":"Evans","year":"1989"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJM199501053320112","article-title":"Epstein-Barr virus - an old dog with new tricks","volume":"332","author":"Leibowitz","year":"1995","journal-title":"Editorial. N Engl J Med"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB16","first-page":"1153","article-title":"Selective transformation of B lymphocytes by EB virus","volume":"ii","author":"Pattengale","year":"1973","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0140-6736(79)90643-3","article-title":"Increased tendency to spontaneous in vitro lymphocyte transformation in clinically active multiple sclerosis","volume":"ii","author":"Fraser","year":"1979","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/WNL.35.3.435","article-title":"Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis","volume":"35","author":"Larsen","year":"1985","journal-title":"Neurolow"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archneur.1980.00500510052009","article-title":"Epstein-Barr virus antibodies in multiple sclerosis","volume":"38","author":"Sumaya","year":"1980","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB20","first-page":"94","article-title":"Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis","volume":"37","author":"Bray","year":"1983","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ana.410170412","article-title":"Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis","volume":"17","author":"Sumaya","year":"1985","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/BF01973638","article-title":"Epstein-Barr virus infection in HIV-positive patients","volume":"12","author":"Telenti","year":"1993","journal-title":"Eur J Clin Microbiol"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB23","first-page":"182","article-title":"Infectious mononucleosis at the U.S. Military Academy. A prospective study of a single class over four years","volume":"47","author":"Hallee","year":"1974","journal-title":"Yale J Biol Med"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB24","first-page":"66","article-title":"The geography of multiple sclerosis reflects genetic susceptibility","volume":"2","author":"Bulman","year":"1992","journal-title":"J Trop Geogr Neurol"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0301-0082(95)80008-V","article-title":"Migrant studies in multiple sclerosis","volume":"47","author":"Gale","year":"1995","journal-title":"Prog Neurobiol"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB26","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/WNL.35.5.672","article-title":"Epidemiology of multiple sclerosis in US veterans: III. Migration and the risk of MS","volume":"35","author":"Kurtzke","year":"1985","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/jnnp.56.2.167","article-title":"Symptomatic Epstein-Barr virus infection and multiple sclerosis","volume":"56","author":"Martyn","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000110248","article-title":"Epidemiological investigations of the association between infectious mononucleosis and multiple sclerosis","volume":"10","author":"Lindberg","year":"1991","journal-title":"Neuroepidemiology"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/135245859500100203","article-title":"Increased risk of multiple sclerosis after late Epstein-Barr virus infection","volume":"1","author":"Haahr","year":"1995","journal-title":"Multiple Sclerosis: Clin Lab Res"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB30","first-page":"17","volume-title":"Methodology of enquiries into disease clustering","author":"Knox","year":"1989"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB31","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/oxfordjournals.aje.a115972","article-title":"Clustering of residence of multiple sclerosis patients at age 13-20 years in Hordeland, Norway","volume":"133","author":"Riise","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB32","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.42.2.278","article-title":"Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection","volume":"42","author":"Bray","year":"1992","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB33","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1056\/NEJM197502202920804","article-title":"Primary Epstein-Barr virus infections in acute neurologic diseases","volume":"292","author":"Grose","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0306-9877(88)90024-2","article-title":"Multiple sclerosis etiology - an Epstein-Barr Virus Hypothesis","volume":"25","author":"Warner","year":"1988","journal-title":"Med Hypotheses"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB35","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1212\/WNL.42.9.1798","article-title":"Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSE and two pentapeptide sequence identities between EBNA and myelin basic protein","volume":"42","author":"Bray","year":"1992","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB36","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/jnnp.57.8.975","article-title":"Absence of Epstein-Barr virus RNA in multiple sclerosis as assessed by in situ hybridisation","volume":"51","author":"Hilton","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB37","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0092-8674(95)90348-8","article-title":"Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein","volume":"80","author":"Wucherpfennig","year":"1995","journal-title":"Cell"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4049\/jimmunol.134.1.211","article-title":"Human immune response to synthetic peptides from the Epstein-Barr nuclear antigen","volume":"134","author":"Rhodes","year":"1985","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB39","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1084\/jem.165.4.1026","article-title":"Autoantibodies in infectious mononucleosis have specificity for the glycine-alanine repeating region of the Epstein-Barr virus nuclear antigen","volume":"165","author":"Rhodes","year":"1987","journal-title":"J exp Med"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0165-5728(96)00069-0","article-title":"An Epstein-Barr virus-related cross reactive autoimmune response in multiple sclerosis in Norway","volume":"69","author":"Vaughan","year":"1996","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB41","first-page":"1161","article-title":"Structural determinants outside of the leucine zipper influence the interaction of CREB and ATF-2: interaction of CREB with ATF-2 blocks E1a: ATF-2 complex formation","volume":"8","author":"Abdel-Hafiz","year":"1993","journal-title":"Oncogene"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/j.1460-2075.1993.tb05680.x","article-title":"Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein","volume":"12","author":"Dam","year":"1993","journal-title":"EMBO J"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB43","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/0092-8674(90)90686-9","article-title":"A specific member of the ATF transcription activation by the adenovirus E1a protein","volume":"61","author":"Liu","year":"1990","journal-title":"Cell"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB44","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1128\/MCB.13.1.561","article-title":"Transcriptional activation by the adenovirus larger E1a product is mediated by members of the cellular transcription factor ATF family which can directly associate with E1a","volume":"13","author":"Chatton","year":"1993","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB45","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/0092-8674(91)90557-F","article-title":"The E2F transcription factor is a cellular target for the RB protein","volume":"65","author":"Chellappan","year":"1991","journal-title":"Cell"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB46","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1128\/JVI.67.9.5235-5246.1993","article-title":"Chronic human immunodeficiency virus type 1 infection stimulates distinct NF-betaB\/rel DNA binding activities in myelomonoblastic cells","volume":"67","author":"Roulston","year":"1993","journal-title":"J Virol"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB47","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1073\/pnas.70.11.3175","article-title":"Biological and biochemical evidence for an interaction between Marek's disease herpesvirus and avian Ieukosis virus in vivo","volume":"70","author":"Peters","year":"1973","journal-title":"PNAS U S A"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0882-4010(91)90060-N","article-title":"Interactions between herpesviruses and retroviruses: implications in the initiation of disease","volume":"10","author":"Evermann","year":"1991","journal-title":"Microb Pathog"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0966-842X(94)90668-8","article-title":"Retrovirus insertion into herpesviruses","volume":"2","author":"Isfort","year":"1994","journal-title":"Trends Microbiol"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB50","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1128\/JVI.70.3.1784-1791.1996","article-title":"Cyclic AMP-responsive element-dependent activation of Epstein-Barr virus zebra promoter by human herpesvirus 6","volume":"70","author":"Flamand","year":"1996","journal-title":"J Virol"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB51","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/299367a0","article-title":"Unique cell line harbouring both Epstein-Barr virus and adult T-cell leukaemia virus, established from leukaemia patients","volume":"299","author":"Yamanamoto","year":"1982","journal-title":"Nature"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB52","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1006\/viro.1995.1269","article-title":"Transmissable retrovirus in Epstein-Barr virus-producer B95-8 cells","volume":"209","author":"Sun","year":"1995","journal-title":"Virology"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB53","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/ijc.2910430625","article-title":"Induction of Epstein-Barr virus in B-lymphoblastoid cells by human immunodeficiency virus type 1","volume":"43","author":"Lai","year":"1989","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB54","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/BF00868517","article-title":"Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study","volume":"243","author":"Lycke","year":"1996","journal-title":"J Neurol"},{"key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB55","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/clpt.1993.196","article-title":"Pharmacokinetics of the acyclovir pro-drug, valaciclovir after escalating single-and multiple-dose administration to normal volunteers","volume":"54","author":"Weller","year":"1993","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl B","key":"10.1111\/j.1600-0404.1997.tb08151.x-BIB56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jac\/12.suppl_B.19","article-title":"The spectrum of antiviral activity of acyclovir in vitro and in vivo","volume":"12","author":"Collins","year":"1983","journal-title":"J Antimicrob Chemother"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.1997.tb08151.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.1997.tb08151.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T14:14:52Z","timestamp":1709993692000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.1997.tb08151.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,2]]},"references-count":56,"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.1997.tb08151.x","relation":{},"ISSN":["0001-6314","1600-0404"],"issn-type":[{"value":"0001-6314","type":"print"},{"value":"1600-0404","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,2]]}}}